Immune checkpoint inhibitors (ICIs), such as programmed death 1 (PD-1) or programmed death ligand 1 (PD-L1) inhibitors, destroy tumor cells via the PD-L1/PD-1 pathway and reactivate effector T cells [8]. The gene discussed is CD274; the disease is neoplasm.